Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | ADAMTSL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ADAMTSL5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | ADARB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | ADD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ADGRB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | ADGRF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ADGRL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ADGRV1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |